Evidence map›Paper›PMID 32420871›Full record

ArticleeLife2020

A helminth-derived suppressor of ST2 blocks allergic responses.

Francesco Vacca, Caroline Chauché, Abhishek Jamwal, Elizabeth C Hinchy, Graham Heieis, Holly Webster, Adefunke Ogunkanbi, Zala Sekne, William F Gregory, Martin Wear and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Early Origins of Asthma and Allergies: Clues From Studies in China.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Review
  9. Review
  10. Modulation of the Immune Response by Nematode Derived Molecules.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Francesco VaccaCentre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom.ORCID 0000-0001-6808-5221
Caroline ChauchéCentre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom.
Abhishek JamwalDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.
Elizabeth C HinchyBioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Graham HeieisInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Holly WebsterInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Adefunke OgunkanbiDivision of Cell Signalling and Immunology, School of Life Sciences, Wellcome Trust Building, University of Dundee, Dundee, United Kingdom.
Zala SekneDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.
William F GregoryCentre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom.
Martin WearThe Edinburgh Protein Production Facility (EPPF), Wellcome Trust Centre for Cell Biology (WTCCB), University of Edinburgh, Edinburgh, United Kingdom.
Georgia Perona-WrightInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Matthew K HigginsDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-2870-1955
Josquin A NysBioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
E Suzanne CohenBioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Henry J McSorleyCentre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom.ORCID 0000-0003-1300-7407
AstraZeneca (United Kingdom) · GBUniversity of Glasgow · GBUniversity of Oxford · GBQueen's Medical Centre · GBUniversity of Dundee · GBUniversity of Cambridge · GBWellcome Centre for Cell Biology · GB

Funding

Medical Research Council MR/S000593/1Medical Research Council MR/S000593/2Medical Research Council MR/S009779/1
6 · The paper itself

Abstract

The IL-33-ST2 pathway is an important initiator of type 2 immune responses. We previously characterised the HpARI protein secreted by the model intestinal nematode

Indexed as

AlternariaAnimalsAntigens, HelminthAsthmaCell LineHumansImmunologic FactorsInterleukin-1 Receptor-Like 1 ProteinInterleukin-33MiceMice, Inbred BALB CMice, Inbred C57BLNematospiroides dubiusOvalbuminAntigens, HelminthIL1RL1 protein, humanIl1rl1 protein, mouseIL33 protein, humanImmunologic FactorsInterleukin-1 Receptor-Like 1 ProteinInterleukin-33OvalbuminallergyasthmaHelminthhumanIL-33immunologyinfectious diseaseinflammationmicrobiologymouseparasiteST2

Identifiers

PMID32420871
PMCPMC7234810
OpenAlexW3026467956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.